BD Selects Torrey View for San Diego Reagent Innovation Center

Medical technology company Becton, Dickinson and Company (BD) recently selected Torrey View by Breakthrough as home for an expanded San Diego Reagent Innovation Center for its growing BD Biosciences business, leasing the campus’ largest planned building. At 220,000 square feet, BD Biosciences will occupy more than 40 percent of Torrey View’s total available space.

Life sciences developer Breakthrough Properties was formed through a joint venture of Tishman Speyer and Bellco Capital.

“BD is exactly the type of dynamic and fast-growing firm we had in mind when we set out to create this life science campus,” said Susie Harborth, executive vice president for operations at Breakthrough Properties.

Torrey View is a 10-acre life sciences research and development campus that Breakthrough is creating alongside its co-equity partner Mitsui Fudosan America. Located within San Diego’s Del Mar Heights life sciences cluster and adjacent to biopharma workforce housing, Torrey View will feature three research and development buildings, and a tenant clubhouse.

“Our new facility in San Diego will aid in elevating our research, development and operations capabilities and position BD for exciting growth,” says Puneet Sarin, worldwide president for BD Biosciences. “BD Biosciences is a cornerstone of BD’s purpose to advance the world of health, providing researchers with innovative tools that drive a deeper understanding of the immune system and unlock its unique power to fight disease.”